Literature DB >> 18564983

Risk factors for islet loss during culture prior to transplantation.

Tatsuya Kin1, Peter Senior, Doug O'Gorman, Brad Richer, Abdul Salam, Andrew Mark James Shapiro.   

Abstract

Culturing islets can add great flexibility to a clinical islet transplant program. However, a reduction in the islet mass has been frequently observed during culture and its degree varies. The aim of this study was to identify the risk factors associated with a significant islet loss during culture. One-hundred and four islet preparations cultured in an attempt to use for transplantation constituted this study. After culture for 20 h (median), islet yield significantly decreased from 363 309 +/- 12 647 to 313 035 +/- 10 862 islet equivalent yield (IE) (mean +/- SE), accompanied by a reduction in packed tissue volume from 3.9 +/- 0.1 to 3.0 +/- 0.1 ml and islet index (IE/islet particle count) from 1.20 +/- 0.04 to 1.05 +/- 0.04. Culture did not markedly alter islet purity or percent of trapped islet. Morphology score and viability were significantly improved after culture. Of 104 islet preparations, 37 suffered a substantial islet loss (> 20%) over culture. Factors significantly associated with risk of islet loss identified by univariate analysis were longer cold ischemia time, two-layer method (TLM) preservation, lower islet purity, and higher islet index. Multivariate analysis revealed that independent predictors of islet loss were higher islet index and the use of TLM. This study provides novel information on the link between donor- isolation factors and islet loss during culture.

Entities:  

Mesh:

Year:  2008        PMID: 18564983     DOI: 10.1111/j.1432-2277.2008.00719.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  47 in total

1.  Preculturing Islets With Adipose-Derived Mesenchymal Stromal Cells Is an Effective Strategy for Improving Transplantation Efficiency at the Clinically Preferred Intraportal Site.

Authors:  Chloe L Rackham; Paramjeet K Dhadda; Aurélie M Le Lay; Aileen J F King; Peter M Jones
Journal:  Cell Med       Date:  2014-03-24

2.  Effects of activin A on survival, function and gene expression of pancreatic islets from non-diabetic and diabetic human donors.

Authors:  Melissa L Brown; Nathan Ungerleider; Lara Bonomi; Danielle Andrzejewski; Amy Burnside; Alan Schneyer
Journal:  Islets       Date:  2014       Impact factor: 2.694

3.  Fibroblast growth factor receptor 5 (FGFR5) is a co-receptor for FGFR1 that is up-regulated in beta-cells by cytokine-induced inflammation.

Authors:  Romario Regeenes; Pamuditha N Silva; Huntley H Chang; Edith J Arany; Andrey I Shukalyuk; Julie Audet; Dawn M Kilkenny; Jonathan V Rocheleau
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

Review 4.  Recent progress in pancreatic islet transplantation.

Authors:  Takashi Kuise; Hirofumi Noguchi
Journal:  World J Transplant       Date:  2011-12-24

5.  Integration of mesenchymal stem cells into islet cell spheroids improves long-term viability, but not islet function.

Authors:  Sonia Rawal; S Janette Williams; Karthik Ramachandran; Lisa Stehno-Bittel
Journal:  Islets       Date:  2017-06-29       Impact factor: 2.694

Review 6.  Effect of co-culture of mesenchymal stem/stromal cells with pancreatic islets on viability and function outcomes: a systematic review and meta-analysis.

Authors:  Bianca Marmontel de Souza; Ana Paula Bouças; Fernanda Dos Santos de Oliveira; Karina Pires Reis; Patrícia Ziegelmann; Andrea Carla Bauer; Daisy Crispim
Journal:  Islets       Date:  2017-03-04       Impact factor: 2.694

7.  In Vitro Platform for Studying Human Insulin Release Dynamics of Single Pancreatic Islet Microtissues at High Resolution.

Authors:  Patrick M Misun; Burçak Yesildag; Felix Forschler; Aparna Neelakandhan; Nassim Rousset; Adelinn Biernath; Andreas Hierlemann; Olivier Frey
Journal:  Adv Biosyst       Date:  2020-01-29

8.  Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes.

Authors:  J S Kaddis; J S Danobeitia; J C Niland; T Stiller; L A Fernandez
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

9.  FEM-based oxygen consumption and cell viability models for avascular pancreatic islets.

Authors:  Peter Buchwald
Journal:  Theor Biol Med Model       Date:  2009-04-16       Impact factor: 2.432

10.  Pancreatic islet transplantation.

Authors:  Maria Lúcia Corrêa-Giannella; Alexandre S Raposo do Amaral
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.